<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04166968</url>
  </required_header>
  <id_info>
    <org_study_id>ITSTUDYTDCS-45-2019</org_study_id>
    <nct_id>NCT04166968</nct_id>
  </id_info>
  <brief_title>Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery</brief_title>
  <official_title>Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Centro San Giovanni di Dio Fatebenefratelli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>San Gerardo Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maggiore Bellaria Hospital, Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero, Universitaria Pisana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondazione Don Carlo Gnocchi Onlus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Universitaria Integrata Verona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Unit√† Sanitaria Locale di Piacenza</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliero Universitaria di Cagliari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedale Policlinico San Martino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>I.R.C.C.S. Fondazione Santa Lucia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituti Clinici Zucchi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedali Riuniti di Foggia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>IRCCS Centro San Giovanni di Dio Fatebenefratelli</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several previous studies have used tDCS as a neuromodulation tool, showing improvements in
      several diseases (Lefaucheur et al., 2017). Based on these observations, it is believed that
      the use of tDCS in combination with specific motor training may provide the opportunity to
      induce behavioral improvements in patients with motor deficits. As shown in previous reports
      brain stimulation can, in fact, interact with the intrinsic ability of the brain to &quot;repair&quot;
      damaged brain functions, increasing the involvement of compensatory functional networks and
      thus inducing neuroplasticity. If these low-cost, easy-to-use stimulation techniques prove to
      be useful in improving motor deficits with long-term effects, the current study would open up
      new and interesting avenues in the field of neurorehabilitation. Given the potential
      long-lasting effects of tDCS, there is currently a growing interest in the clinical sector
      with the aim to reduce motor deficits in patients with brain injury. The most widely used
      protocols in stroke patients include the application of either anodal on the hypsilesional
      hemisphere or cathodal tDCS on the unaffected hemisphere (contralateral), so as to increase
      and decrease the excitability of the motor cortex, respectively (Nitsche and Paulus, 2001).

      The main objective of this study is to evaluate the effectiveness of transcranial direct
      current stimulation in enhancing the functional recovery of the upper limb of stroke patients
      after three weeks of neuromotor training and subsequent follow-up. The secondary objective is
      to evaluate the treatment effects on balance, gait, motor dexterity and disability, besides
      the functional recovery of the lower limb.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 10, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The present study will be conducted in over 15 recruiting centers with a randomized double-blind design. Post-stroke patients will be randomly assigned to 3 parallel groups: Control Group (neuromotor training and sham stimulation), Experimental Group 1 (neuromotor training and cathodal tDCS over the unaffected hemisphere), Group 2 (neuromotor training and anodal tDCS over the affected hemisphere). Participants will be further partitioned on the basis of the acute/subacute and subacute/chronic stages (7-90 and 91 days from lesion onset, respectively).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Both participants and experimenters will be prevented from having knowledge of the assigned stimulation protocol. To do so, the investigator will create a series of numbers paired with real and sham interventions while the outcome assessor will be aware of the patient-number association only.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from Baseline Fugl Meyer Assessment Scale (FMA)</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>Performance-based assessment of sensorimotor impairment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline Box &amp; Block Test (B&amp;B)</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>test for manual dexterity of upper extremity function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline Barthel Index (BI)</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>measure of daily living activities in relation to personal care and mobility of the patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline Trunk Control Test (TCT)</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>assessment of the deteriorations in trunk control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline Berg Balance Scale ( BBS)</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>test of a person's static and dynamic balance abilities</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline 10 Meters Walking Test</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>evaluation of functional mobility, gait, and vestibular function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes from Baseline Functional Ambulatory Classification (FAC)</measure>
    <time_frame>End of 1st week; End of 2nd week; End of 3rd week; 90 days follow-up</time_frame>
    <description>clinically meaningful outcome measure of mobility</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">162</enrollment>
  <condition>Stroke, Ischemic</condition>
  <condition>Stroke Hemorrhagic</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>neuromotor training and placebo stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>neuromotor training and cathodal stimulation over the unaffected hemisphere</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>neuromotor training and anodal stimulation over the affected hemisphere</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anodal transcranial direct current stimulation (A-tDCS)</intervention_name>
    <description>Anodal tDCS will be performed for 20 minutes over the affected hemisphere with an intensity set to 2 mA</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cathodal transcranial direct current stimulation (C-tDCS)</intervention_name>
    <description>Cathodal tDCS will be performed for 20 minutes over the unaffected hemisphere with an intensity set to 2 mA</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham stimulation (sham-tDCS)</intervention_name>
    <description>placebo stimulation</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neuromotor training</intervention_name>
    <description>conventional neuromotor treatment</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First-ever ischemic stroke

          -  Red or white stroke

          -  Barthel Index &gt; 90 before lesion onset

        Exclusion Criteria:

          -  Previous inborn neurological disease

          -  Previous acquired neurological disease

          -  Previous or current major psychiatric illness

          -  Epilepsy or anticonvulsant treatment

          -  Use of calcium channel blocker drugs

          -  Treatments with other technologies (robotics, FES, etc.)

          -  Neurolytic treatments with botulinum toxin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Miniussi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS Centro San Giovanni di Dio Fatebenefratelli</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Concetta Pellicciari, PhD</last_name>
    <phone>+39 030 3501597</phone>
    <email>studioitalianotdcs@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>IRCCS Centro San Giovanni di Dio Fatebenefratelli</name>
      <address>
        <city>Brescia</city>
        <state>Lombardia</state>
        <zip>25125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Miniussi</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 13, 2019</study_first_submitted>
  <study_first_submitted_qc>November 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Centro San Giovanni di Dio Fatebenefratelli</investigator_affiliation>
    <investigator_full_name>Carlo Miniussi</investigator_full_name>
    <investigator_title>Professor, PhD</investigator_title>
  </responsible_party>
  <keyword>transcranial direct current stimulation</keyword>
  <keyword>stroke rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

